EMD 57445, the selective σ receptor ligand, has no effect on the 5-hydroxytryptamine system

Polish Journal of Pharmacology

Volumn 49, Issue 6, 1997, Pages 489-493

  Skuza, Grazyna ^a   Rogóz, Zofia ^a   Gołembiowska, Krystyna ^a  

^a INSTITUTE OF PHARMACOLOGY   (Poland)

Author keywords

5 HT and 5 HIAA levels; 5 Hydroxytryptamine (5 HT) receptor subpopulations; Behavior; EMD 5744

Indexed keywords

(3 CHLOROPHENYL)PIPERAZINE; 5 HYDROXYINDOLEACETIC ACID; 5 HYDROXYTRYPTOPHAN; 8 HYDROXY 2 PROPYLAMINOTETRALIN; PANAMESINE; SIGMA OPIATE RECEPTOR; SIGMA RECEPTOR LIGAND; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BEHAVIOR; BRAIN REGION; CONTROLLED STUDY; DRUG EFFECT; HEAD TWITCH; HYPOTHERMIA; INTRAPERITONEAL DRUG ADMINISTRATION; MALE; MOUSE; NONHUMAN; PHARMACODYNAMICS; RAT; SEROTONINERGIC SYSTEM;

5-HYDROXYTRYPTOPHAN; 8-HYDROXY-2-(DI-N-PROPYLAMINO)TETRALIN; ANIMALS; ANTIPSYCHOTIC AGENTS; BEHAVIOR, ANIMAL; BRAIN; HYDROXYINDOLEACETIC ACID; HYPOTHERMIA; LIGANDS; MALE; MICE; OXAZOLES; PIPERAZINES; PIPERIDINES; RATS; RATS, WISTAR; RECEPTORS, SEROTONIN; RECEPTORS, SIGMA; SEROTONIN; SEROTONIN AGONISTS;

EID: 0031452794     PISSN: 12306002     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. 1A agonist 8-OH-DPAT in the rat. Pharmacol. Toxicol., 1989, 64, 3-5.
2. Ahlenius S., Hillegaart V., Wijkström A.: Regionselective effects by 8-OH-DPAT on rat brain dopamine synthesis in vivo. Neurochem. Int., 1988, 13, 80-89.
3. 2 receptor affinity and also influenced by other transmitters. Acta Pharmacol. Toxicol., 1984, 55, 363-372.
4. Bartoszyk G. D., Bender H. M., Hellmann J., Schnorr C., Seyfried C. A.: EMD 57445: a selective sigma receptor ligand with the profile of an atypical neuroleptic. CNS Drug Rev., 1996, 2, 175-194.
5. Bartoszyk G. D., Bender H. M., Heusener A., Schnorr C.: Pharmacology of the potential antipsychotic EMD 57445 in animals and humans. Eur. Neuropsychopharmacol., 1995, 5, 331.
6. Bartoszyk G. D., Greiner H. E., Harting J., Stohrer M., Seyfried C. A.: Pharmacological profile of the atypical neuroleptic drug EMD 57445. Soc. Neurosci. Abstr., 1992, 18, 584.
7. Ceulemans D., Van Doren J., Nutys J., De Wit P.: Therapeutic efficacy of serotonin and dopamine antagonist on positive and negative symptoms of chronic schizophrenic patients. Int. J. Neurosci., 1987, 32, 236-242.
8. Corne S. J., Pickering R. W., Warner B. T.: A method of assessing the effects of drugs on the central actions of 5-hydroxy-tryptamine. Brit. J. Pharmacol., 1963, 20, 106-120.
9. Debonnel G., De Montigny C.: Modulation of NMDA and dopaminergic neurotransmissions by sigma ligands: possible implications for the treatment of psychiatric disorders. Life Sci., 1996, 58, 721-734.
10. Golembiowska K.: Ipsapirone, a new anxiolytic drug, stimulates catecholamine turnover in various regions of the rat brain. Pol. J. Pharmacol. Pharm., 1990, 42, 143-150.
11. 2-dopamine receptor binding in the post-mortem human brain. An autoradiographic study. Eur. Neuropsychopharmacol., 1995, 5, 19-25.
12. Jackson D. M., Mohell N., Bengtsson A., Malmberg Å.: What are typical neuroleptics and how do they work? In: New Generation of Antipsychotic Drugs: Novel Mechanism of Action. Eds. Brunello N., Mendlewicz J., Racagni M., Karger, Basel, 1993, 27-38.
13. 1c receptors. Brit. J. Pharmacol., 1988, 137-147.
14. Leysen J. E., Gommeren W., Eans A., de Chaffoy de Courcelles D., Stoof J. C., Janssen P. A. J.: Biochemical profile of risperidone, a new antipsychotic. J. Pharmacol. Exp. Ther., 1988, 247, 661-370.
15. 1B receptors? J. Neural Transm. 1988, 73, 43-55.
16. Maj J., Rogóz Z., Skuza G., Mazela H.: Neuropharmacological profile of EMD 57445, a sigma receptor ligand with potential antipsychotic activity. Eur. J. Pharmacol., 1996, 315, 235-245.
17. Meltzer H. Y., Stahl S. M.: The dopamine hypothesis of schizophrenia: a review. Schizophrenia Bull., 1976, 2, 19-76.
18. Przegaliriski E., Ismaiel A. M., Chojnacka-Wójcik E., Budziszewska B., Tatarczyńska E., Błaszczyńska E.: The behavioural but not hypothermic or corticosterone, response to 8-hydroxy-2-(Di-n-propylamino)-tetralin, is antagonized by NAN-190 in the rat. Neuropharmacology, 1990, 29, 521-526.
19. Schotte A., Janssen P. F. M., Megens A. A., Leysen J. E.: Occupancy of central neurotransmitter receptors by risperidone, clozapine and haloperidol, measured ex vivo by quantitative autoradiography. Brain Res., 1993, 631, 191-202.
20. Skuza G., Gołembiowska K., Wedzony K.: The effect of EMD 57445 on the turnover and release of dopamine. Pol. J. Pharmacol., in press.
21. 1 receptor and catecholaminergic systems in the behavioural response to 8-hydroxy-2-(Di-n-propylamino)-tetralin in the rat. Eur. J. Pharmacol., 1985, 106, 271-282.
22. Walker J. M., Bowen W. D., Walker F. O., Matsumoto R. R., De Costa B. R., Rice K. C.: Sigma receptors: biology and function. Pharmacol. Rev., 1990, 42, 355-402.